We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$141M
AUM Growth
+$23.2M
Cap. Flow
+$19.2M
Cap. Flow %
13.6%
Top 10 Hldgs %
39.69%
Holding
74
New
8
Increased
33
Reduced
5
Closed
4

Top Buys

Rank Stock Value
1
TLGT
Teligent, Inc
TLGT
+$4.57M
2
HBIO icon
Harvard Bioscience
HBIO
+$4.38M
3
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$3.79M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$3.61M
5
TECH icon
Bio-Techne
TECH
+$3.05M

Top Sells

Rank Stock Value
1
TEAR
TearLab Corporation
TEAR
+$4.75M
2
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$3.31M
3
ACCL
Accelrys Inc
ACCL
+$2.99M
4
ATRC icon
AtriCure
ATRC
+$2.86M
5
ARTC
ARTHROCARE CORP
ARTC
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 85.86%
2 Consumer Staples 2.17%
3 Financials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
1
AtriCure
ATRC
$1.92B
$8.65M 6.13%
459,709
-139,339
-23% -$2.86M
SPNC
2
DELISTED
Spectranetics Corp
SPNC
$8.21M 5.82%
270,934
+32,930
+14% +$902K
TLGT
3
DELISTED
Teligent, Inc
TLGT
$6.41M 4.54%
+113,378
New +$4.57M
NEO icon
4
NeoGenomics
NEO
$1.96B
$5.1M 3.61%
1,469,078
+373,377
+34% +$1.4M
SRGA
5
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$5.06M 3.58%
41,315
-5,524
-12% -$598K
LGND icon
6
Ligand Pharmaceuticals
LGND
$5.76B
$4.72M 3.34%
112,470
+15,902
+16% +$663K
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
$4.59M 3.25%
976,799
+116,733
+14% +$587K
HBIO icon
8
Harvard Bioscience
HBIO
$27.5M
$4.56M 3.23%
+96,150
New +$4.38M
ENZ
9
DELISTED
Enzo Biochem, Inc.
ENZ
$4.38M 3.1%
+1,053,702
New +$3.61M
QDEL icon
10
QuidelOrtho
QDEL
$1.14B
$4.36M 3.09%
159,662
+18,632
+13% +$544K
AKRX
11
DELISTED
Akorn Inc
AKRX
$4.36M 3.09%
197,956
+25,681
+15% +$600K
NVDQ
12
DELISTED
Novadaq Technologies Inc.
NVDQ
$4.31M 3.05%
193,450
+23,368
+14% +$464K
OMCL icon
13
Omnicell
OMCL
$1.61B
$4.09M 2.9%
142,998
+18,557
+15% +$508K
STRM
14
DELISTED
Streamline Health Solutions
STRM
$3.82M 2.71%
50,642
+17,928
+55% +$1.67M
STAA icon
15
STAAR Surgical
STAA
$1.21B
$3.63M 2.57%
192,887
+28,866
+18% +$465K
LCI
16
DELISTED
Lannett Company, Inc.
LCI
$3.58M 2.53%
25,039
-10,097
-29% -$1.57M
OXFD
17
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.52M 2.49%
+175,347
New +$3.79M
STKL
18
DELISTED
SunOpta
STKL
$3.06M 2.17%
258,986
-108,294
-29% -$1.09M
LAB icon
19
Standard BioTools
LAB
$340M
$3.02M 2.14%
68,415
+10,240
+18% +$451K
TECH icon
20
Bio-Techne
TECH
$11.2B
$2.9M 2.05%
+135,704
New +$3.05M
SPPI
21
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2.74M 1.94%
+349,267
New +$2.96M
CPHD
22
DELISTED
Cepheid Inc
CPHD
$2.69M 1.9%
52,127
+7,273
+16% +$370K
ALKS icon
23
Alkermes
ALKS
$8.22B
$2.66M 1.88%
60,255
+9,027
+18% +$429K
NPSP
24
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$2.37M 1.68%
79,099
+10,854
+16% +$374K
CLDX icon
25
Celldex Therapeutics
CLDX
$2.99B
$2.34M 1.66%
8,837
+1,097
+14% +$420K
1
2 3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, First Light Asset Management held 74 positions worth $141M, up 20% from $118M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

First Light Asset Management deployed $19.2M of net new capital in Q1 2014, opening 8 new positions and adding to 33 existing holdings. Its largest new stake was Teligent, Inc: 113,378 shares worth $6.41M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 76% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was AtriCure, an estimated $2.86M trimmed.

  • First Light Asset Management's largest Q1 2014 buy was Teligent, Inc: 113,378 shares worth $6.41M.
  • First Light Asset Management added most to Streamline Health Solutions in Q1 2014, an estimated $1.67M increase.
  • First Light Asset Management's biggest Q1 2014 reduction was AtriCure, cutting an estimated $2.86M.
  • First Light Asset Management fully exited TearLab Corporation in Q1 2014, selling an estimated $4.75M.
  • First Light Asset Management's ten largest holdings make up 40% of its $141M portfolio in Q1 2014.
  • First Light Asset Management opened 8 new positions and closed 4 in Q1 2014.
  • First Light Asset Management's portfolio value rose 20% quarter-over-quarter to $141M.

Based on First Light Asset Management's 13F filing for Q1 2014, filed 15 May 2014.